Premium
TAK1‐mediated transcriptional activation of CD28‐responsive element and AP‐1‐binding site within the IL‐2 promoter in Jurkat T cells
Author(s) -
Sakurai Hiroaki,
Singhirunnusorn Pattama,
Shimotabira Emi,
Chino Atsushi,
Suzuki Shunsuke,
Koizumi Keiichi,
Saiki Ikuo
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.10.059
Subject(s) - jurkat cells , cd28 , kinase , activator (genetics) , microbiology and biotechnology , chemistry , transcription factor , map kinase kinase kinase , p38 mitogen activated protein kinases , protein kinase c , protein kinase a , t cell , biology , in vitro , receptor , biochemistry , gene , cytotoxic t cell , immunology , immune system
We focused on the functional involvement of transforming growth factor‐β‐activated kinase 1 (TAK1) in transcriptional regulation of interleukin‐2 (IL‐2) in T cells. Costimulation of Jurkat cells with 12‐ O ‐tetradecanoylphorbol‐13‐acetate and A23187 leads to a rapid phosphorylation of TAK1 and TAK1‐binding protein 1 (TAB1), critical for TAK1 activation. A specific inhibitor of TAK1 blocked production of IL‐2. In addition, overexpression of TAK1 and TAB1 induced secretion of IL‐2. CD28‐responsive element/activator protein‐1‐binding site (RE/AP) within the IL‐2 promoter was a functional target for TAK1. The RE/AP‐driven transcription was regulated by TAK1‐mediated activation of the c‐Jun NH 2 ‐terminal kinase, p38 and IκB kinase. These results indicate that TAK1 plays a critical role in T cell activation by controlling production of IL‐2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom